Andreas Müller-Schiffmann

Title: Andreas Müller-Schiffmann: Innovator in Prion Protein Research

Introduction

Andreas Müller-Schiffmann is a notable inventor based in Odenthal, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target prion proteins. His innovative work has implications for understanding and treating prion-related diseases.

Latest Patents

Müller-Schiffmann holds a patent for an "Anti-prion protein antibody fragment." This invention relates to an antibody, antibody fragment, or derivative that specifically recognizes a prion protein. It includes a complementarity determining region (CDR), a retro-inverso D-peptide of the CDR, and/or an anti-idiotypic antibody that recognizes the CDR. The patent also covers a nucleic acid molecule encoding the antibody and methods for generating such antibodies that specifically recognize prion proteins.

Career Highlights

Throughout his career, Müller-Schiffmann has worked with various research institutions, contributing to advancements in his field. His work has been instrumental in the development of therapeutic strategies against prion diseases. He has a patent count of 1 patent, showcasing his innovative contributions to biotechnology.

Collaborations

Müller-Schiffmann has collaborated with notable colleagues, including Carsten Korth and Lothar Stitz. These collaborations have furthered research efforts in prion protein studies and antibody development.

Conclusion

Andreas Müller-Schiffmann is a prominent figure in the field of prion protein research, with a focus on antibody development. His innovative patent and collaborations highlight his commitment to advancing biotechnology. His work continues to have a significant impact on the understanding of prion-related diseases.